New Delhi: Covaxin trial in the age group of 2-18 years has been cleared by the Drugs Controller General of India (DCGI) on Thursday. Bharat Biotech International Limited, Hyderabad had proposed to carry out the trial of the vaccine on the age group of 2-18 years.
In the phase Phase II/III clinical trial of the Covid vaccine will be carried out on 525 healthy volunteers by Bharat Biotech.
During the trial two vaccine doses will be injected by intramuscular route at day 0 and day 28. AIIMS (Delhi), AIIMS(Patna) and Meditrina Institute of Medical Sciences, Nagpur are the places for the trial.
Puri: The Puri Chapter of the Indian National Trust for Art and Cultural Heritage (INTACH)…
New Delhi: The ancient Buddhist site of Sarnath in Uttar Pradesh has been inscribed on…
New Delhi: Days of protests at Delhi's Jantar Mantar over the alleged examination paper leak…
New Delhi: Union Education Minister Dharmendra Pradhan on Saturday resigned from the Union Cabinet amid…
Bhubaneswar: In a bid to strengthen passenger safety during the ongoing Rath Yatra festivities, the…
Bhubaneswar: East Coast Railway (ECoR) has announced a series of special trains for Suna Besha…
